Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_J05AP
Extra metadata
List of similar endpoints to
J05AP Antivirals for treatment of HCV infections
based on the number of shared cases.
Broader endpoints:
None
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | - | - | - |
| Unadjusted prevalence (%) | - | - | - |
| Mean age at first event (years) | - | - | - |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: RX_J05AP – J05AP Antivirals for treatment of HCV infections
GWS hits:
before J05AP Antivirals for treatment of HCV infections
after J05AP Antivirals for treatment of HCV infections
Loading survival analyses plot
Loading survival analyses table